XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
UNAUDITED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income
Balance at beginning of period (in shares) at Jun. 27, 2021     115,691          
Balance at beginning of period at Jun. 27, 2021 $ 2,116.5   $ 0.1 $ 3,676.8   $ (1,563.1)   $ 2.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (70.1)         (70.1)    
Unrealized loss on available-for-sale securities (0.8)             (0.8)
Comprehensive loss (70.9)              
Tax withholding on vested equity awards (22.5)     (22.5)        
Stock-based compensation 15.6     15.6        
Exercise of stock options and issuance of shares (in shares)     495          
Exercise of stock options and issuance of shares 0.7     0.7        
Balance at end of period (in shares) at Sep. 26, 2021     116,186          
Balance at end of period at Sep. 26, 2021 2,039.4   $ 0.1 3,670.6   (1,633.2)   1.9
Balance at beginning of period (in shares) at Jun. 27, 2021     115,691          
Balance at beginning of period at Jun. 27, 2021 2,116.5   $ 0.1 3,676.8   (1,563.1)   2.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (233.3)              
Unrealized loss on available-for-sale securities (20.7)              
Comprehensive loss (254.0)              
Balance at end of period (in shares) at Mar. 27, 2022     123,599          
Balance at end of period at Mar. 27, 2022 2,390.4   $ 0.2 4,204.6   (1,796.4)   (18.0)
Balance at beginning of period (in shares) at Sep. 26, 2021     116,186          
Balance at beginning of period at Sep. 26, 2021 2,039.4   $ 0.1 3,670.6   (1,633.2)   1.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (96.7)         (96.7)    
Unrealized loss on available-for-sale securities (3.6)             (3.6)
Comprehensive loss (100.3)              
Tax withholding on vested equity awards (2.8)     (2.8)        
Stock-based compensation 15.7     15.7        
Exercise of stock options and issuance of shares (in shares)     258          
Exercise of stock options and issuance of shares 10.7     10.7        
Issuance of shares related to the extinguishment of convertible notes due September 1, 2023 (in shares)     7,126          
Issuance of shares related to the extinguishment of convertible notes due September 1, 2023 416.2   $ 0.1 416.1        
Balance at end of period (in shares) at Dec. 26, 2021     123,570          
Balance at end of period at Dec. 26, 2021 2,378.9   $ 0.2 4,110.3   (1,729.9)   (1.7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (66.5)         (66.5)    
Unrealized loss on available-for-sale securities (16.3)             (16.3)
Comprehensive loss (82.8)              
Tax withholding on vested equity awards (0.8)     (0.8)        
Stock-based compensation 15.4     15.4        
Exercise of stock options and issuance of shares (in shares)     29          
Exercise of stock options and issuance of shares 0.3     0.3        
Issuance of convertible notes due February 15, 2028 187.6     187.6        
Capped call transactions related to the issuance of convertible notes due December 1, 2029 (108.2)     (108.2)        
Balance at end of period (in shares) at Mar. 27, 2022     123,599          
Balance at end of period at Mar. 27, 2022 $ 2,390.4   $ 0.2 4,204.6   (1,796.4)   (18.0)
Balance at beginning of period (in shares) at Jun. 26, 2022 123,795   123,795          
Balance at beginning of period at Jun. 26, 2022 $ 2,439.3 $ (303.3) $ 0.2 4,228.4 $ (333.0) (1,764.0) $ 29.7 (25.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (26.2)         (26.2)    
Unrealized loss on available-for-sale securities (7.0)             (7.0)
Comprehensive loss (33.2)              
Tax withholding on vested equity awards (16.9)     (16.9)        
Stock-based compensation 23.2     23.2        
Exercise of stock options and issuance of shares (in shares)     415          
Exercise of stock options and issuance of shares 0.5     0.5        
Balance at end of period (in shares) at Sep. 25, 2022     124,210          
Balance at end of period at Sep. 25, 2022 $ 2,109.6   $ 0.2 3,902.2   (1,760.5)   (32.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Adoption of ASU 2020-06 [Extensible Enumeration] Adoption of ASU 2020-06              
Balance at beginning of period (in shares) at Jun. 26, 2022 123,795   123,795          
Balance at beginning of period at Jun. 26, 2022 $ 2,439.3 $ (303.3) $ 0.2 4,228.4 $ (333.0) (1,764.0) $ 29.7 (25.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (216.6)              
Unrealized loss on available-for-sale securities 2.2              
Comprehensive loss $ (214.4)              
Balance at end of period (in shares) at Mar. 26, 2023 124,437   124,437          
Balance at end of period at Mar. 26, 2023 $ 1,706.8   $ 0.2 3,680.6   (1,950.9)   (23.1)
Balance at beginning of period (in shares) at Sep. 25, 2022     124,210          
Balance at beginning of period at Sep. 25, 2022 2,109.6   $ 0.2 3,902.2   (1,760.5)   (32.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (90.9)         (90.9)    
Unrealized loss on available-for-sale securities 3.7             3.7
Comprehensive loss (87.2)              
Tax withholding on vested equity awards (0.4)     (0.4)        
Stock-based compensation 21.4     21.4        
Exercise of stock options and issuance of shares (in shares)     203          
Exercise of stock options and issuance of shares 10.7     10.7        
Capped call transactions related to the issuance of convertible notes due December 1, 2029 (273.9)     (273.9)        
Balance at end of period (in shares) at Dec. 25, 2022     124,413          
Balance at end of period at Dec. 25, 2022 1,780.2   $ 0.2 3,660.0   (1,851.4)   (28.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (99.5)         (99.5)    
Unrealized loss on available-for-sale securities 5.5             5.5
Comprehensive loss (94.0)              
Tax withholding on vested equity awards (0.4)     (0.4)        
Stock-based compensation 20.8     20.8        
Exercise of stock options and issuance of shares (in shares)     24          
Exercise of stock options and issuance of shares $ 0.2     0.2        
Balance at end of period (in shares) at Mar. 26, 2023 124,437   124,437          
Balance at end of period at Mar. 26, 2023 $ 1,706.8   $ 0.2 $ 3,680.6   $ (1,950.9)   $ (23.1)